These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1149628)
1. [Myocardial infarct and ovulation inhibitors]. Zimmermann KG; Siegenthaler W Dtsch Med Wochenschr; 1975 Jun; 100(26):1441-3. PubMed ID: 1149628 [TBL] [Abstract][Full Text] [Related]
2. Myocardial infarction in young women with special reference to oral contraceptive practice. Mann JI; Vessey MP; Thorogood M; Doll SR Br Med J; 1975 May; 2(5965):241-5. PubMed ID: 1169093 [TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785 [TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives and myocardial infarction. Thorneycroft IH Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1393-7. PubMed ID: 2220964 [TBL] [Abstract][Full Text] [Related]
5. [Internal medicine problems regarding contraception. Part I]. Mall-Haefeli M Schweiz Med Wochenschr; 1980 Sep; 110(36):1314-9. PubMed ID: 7444416 [TBL] [Abstract][Full Text] [Related]
6. [Cardiovascular risks of oral contraceptives: dose-response relationship]. Kelleher CC Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220 [TBL] [Abstract][Full Text] [Related]
7. Letter: Myocardial infarction and estrogen therapy in premenopausal women. Rosenberg L; Armstrong B; Jick H N Engl J Med; 1976 Jun; 294(23):1290-1. PubMed ID: 1264157 [TBL] [Abstract][Full Text] [Related]
10. [Oral contraceptives: pharmacotherapy of normal women (author's transl)]. Bühler FR Schweiz Rundsch Med Prax; 1976 Jan; 65(1):3-5. PubMed ID: 1250821 [TBL] [Abstract][Full Text] [Related]
11. Myocardial infarction and other vascular diseases in young women. Role of estrogens and other factors. Jick H; Dinan B; Herman R; Rothman KJ JAMA; 1978 Dec; 240(23):2548-52. PubMed ID: 712957 [TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
13. [Estrogen therapy for the climateric and thromboembolic risk]. Campagnoli C; Prelato L; Rossetti MG Minerva Ginecol; 1980 May; 32(5):429-35. PubMed ID: 7393492 [TBL] [Abstract][Full Text] [Related]
14. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users. Zaki K; Sami G; Nour H Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026 [TBL] [Abstract][Full Text] [Related]
16. Coronary thrombosis in young women on oral contraceptives: report of two cases and review of the literature. Maleki M; Lange RL Am Heart J; 1973 Jun; 85(6):749-54. PubMed ID: 4702663 [TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives and myocardial infarction. Oliver MF Br Med J; 1970 Apr; 2(5703):210-3. PubMed ID: 5443407 [TBL] [Abstract][Full Text] [Related]
18. [Sex steroids and vascular risk]. Rozenbaum H Coeur; 1983; 14(1):91-102. PubMed ID: 12339512 [TBL] [Abstract][Full Text] [Related]
19. Oral contraception and myocardial infarction revisited: the effects of new preparations and prescribing patterns. Adam SA; Thorogood M; Mann JI Br J Obstet Gynaecol; 1981 Aug; 88(8):838-45. PubMed ID: 7260005 [TBL] [Abstract][Full Text] [Related]